Jim Corbett, President and CEO of Alphatec Holdings Inc. (ATEC), announced a new product release at the Canaccord Genuity 34th Annual Growth Conference at the Intercontinental Hotel in Boston.
Alphatec Spine, Inc., a wholly owned subsidiary of Alphatec Holdings, Inc., is a global provider of spinal fusion technologies. The company is the sixth largest global spine company, with 80 U.S. patents. The company and its affiliates market products in the U.S. and internationally via a direct sales force and independent distributors, he said.
FOR THE LATEST TWST MEDICAL DEVICES REPORT, CLICK HERE.
Corbett introduced Arsenal, a new spinal fixation system providing a solution for complex degenerative conditions. It is in a limited market release. Alphatec has released four products in the last 12-18 months, including a method for harvesting bone graft.
Corbett said that the company expects large groups of products to be approved in Brazil and China, but sees the company’s biggest opportunity in the EU, “a market where all of our products are approved,” but without full participation in all of the countries there. While Alphatec has some direct operations in Italy and the UK, “we do intend to get those moving without aggressive spend-forward programs. Some markets we’ll enter, some we may convert.”
Corbett, who is new to the company, said the overall Alphatec focus is on “solid, repeatable execution focused on growth and improving operations.” He promised close tabs on keeping cash flow balance in check.
FOR THE FULL PRESENTATION, CLICK HERE.
Matt Flake, President and CEO of Q2 Holdings Inc (QTWO), Presents at Canaccord Genuity Global Growth Conference
August 15, 2014
Jim Slattery, CFO of Capstone Mining Corp. (TSE:CS), Presents at Canaccord Global Resources in NY
October 16, 2014
Yves J. Ribeill, President and CEO, Scynexis, Inc. (SCYX), Presents at Canaccord Genuity Growth Conference
August 18, 2014
Francois Nader, President and CEO of NPS Pharmaceuticals, Inc. (NPSP), Presents at Canaccord Genuity Growth Conference
August 19, 2014
Dr. Daniel Gold, President and CEO of MEI Pharma Inc (MEIP), Presents at Canaccord Genuity Growth Conference
August 19, 2014
